XLO
Xilio Therapeutics·NASDAQ
--
--(--)
--
--(--)
XLO fundamentals
Xilio Therapeutics (XLO) released its earnings on Aug 14, 2025: revenue was 8.09M (YoY +243.01%), missed estimates; EPS was -2.24 (YoY +33.33%), missed estimates.
Revenue / YoY
8.09M
+243.01%
EPS / YoY
-2.24
+33.33%
Report date
Aug 14, 2025
Earnings Call
7:30 AM on Aug 14, 2025
Meeting link.EPS
Actual | -297.78 | -13.72 | -10.92 | -12.6 | -10.08 | -11.48 | -11.62 | -9.8 | -8.54 | -8.96 | -8.68 | -3.36 | -3.08 | -2.8 | -2.52 | -2.24 |
Forecast | -15.2133 | -15.568 | -14.112 | -10.955 | -12.285 | -10.99 | -12.39 | -12.145 | -11.305 | -8.715 | -1.54 | -3.22 | -3.4533 | -3.0338 | -2.6978 | -1.1032 |
Surprise | -1857.37% | +11.87% | +22.62% | -15.02% | +17.95% | -4.46% | +6.21% | +19.31% | +24.46% | -2.81% | -463.64% | -4.35% | +10.81% | +7.71% | +6.59% | -103.05% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.36M | 2.28M | 1.72M | 2.92M | 8.09M |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.00M | 30.00M | 3.30M | 3.30M | 4.40M | 8.21M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | -92.14% | -30.91% | -47.76% | -33.75% | -1.46% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Xilio Therapeutics next quarter?What guidance did Xilio Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Xilio Therapeutics year over year?What is Xilio Therapeutics's latest dividend and current dividend yield?Did Xilio Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Xilio Therapeutics's revenue and profit?What does Xilio Therapeutics do and what are its main business segments?What were the key takeaways from Xilio Therapeutics’s earnings call?
